Novel Coronavirus (SARS-CoV-2/COVID-19)
This week, the women and men of America’s hospitals and health systems are continuing their heroic efforts caring for tens of thousands of COVID-19 patients.
The Centers for Medicare & Medicaid Services (CMS) April 13 issued guidance implementing legislative provisions specific to enhanced federal funding for Medicaid and Children’s Health Insurance Program, as well as a new state Medicaid option to cover COVID-19 diagnostic testing and services for…
As the COVID-19 surge wanes in different parts of the country, patients' pent up demand to resume their elective surgeries will be immense.
As the COVID-19 surge wanes in different parts of the country, patients’ pent up demand to resume their elective surgeries will be immense. To ensure patients can have elective surgeries as soon as safely possible, a roadmap to guide readiness, prioritization and scheduling has been developed by…
As the COVID-19 surge wanes in different parts of the country, patients’ pent up demand to resume their elective surgeries will be immense. To ensure patients can have elective surgeries as soon as safely possible, the AHA, American College of Surgeons (ACS), American Society of Anesthesiologists (…
President Trump directed the Secretary of Defense to authorize 100% federal cost-sharing for the governors of Iowa, Kansas, Maine, Nebraska, Oklahoma and Vermont to deploy the National Guard to support their respective COVID-19 emergency assistance efforts for up to 31 days.
The Department of Health and Human Services awarded $90 million for Ryan White HIV/AIDS Program recipients as part of the Coronavirus Aid, Relief and Economic Security Act.
The Department of Health and Human Services reached an agreement with General Electric to produce 50,000 ventilators by July 13.
The Food and Drug Administration issued a pair of emergency use authorizations for serology tests to detect for the presence of coronavirus antibodies.
During the COVID-19 emergency, the Food and Drug Administration will not take action in certain circumstances against a registered outsourcing facility for compounding certain drugs to treat hospitalized patients with COVID-19; using a bulk drug substance not on the 503B bulk list; or not meeting…